- call +1-201-465-4211
- email sales@mrinsights.biz
A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder.
Scope of the Report:
Globally, increasing number of people with respiratory diseases and diabetes mellitus are expected to remain the growth drivers for dry powder inhaler devices during the period of study.
The worldwide market for Dry Powder Inhaler Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Dry Powder Inhaler Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer HealthCare
GlaxoSmithKline
Sandoz International
Teva Pharmaceutical Industries
Novartis
AKELA Pharma
Pharmaxis
Hovione FarmaCiencia
Nanotherapeutics
OPKO Health
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsule Based
Blister Based
Reservoir/Cartridge Based
Market Segment by Applications, can be divided into
Hospitals and Clinics
Others
There are 15 Chapters to deeply display the global Dry Powder Inhaler Devices market.
Chapter 1, to describe Dry Powder Inhaler Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dry Powder Inhaler Devices, with sales, revenue, and price of Dry Powder Inhaler Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dry Powder Inhaler Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dry Powder Inhaler Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dry Powder Inhaler Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Dry Powder Inhaler Devices Introduction
1.2 Market Analysis by Type
1.2.1 Capsule Based
1.2.2 Blister Based
1.2.3 Reservoir/Cartridge Based
1.3 Market Analysis by Applications
1.3.1 Hospitals and Clinics
1.3.2 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer HealthCare
2.1.1 Business Overview
2.1.2 Dry Powder Inhaler Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer HealthCare Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Dry Powder Inhaler Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sandoz International
2.3.1 Business Overview
2.3.2 Dry Powder Inhaler Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sandoz International Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical Industries
2.4.1 Business Overview
2.4.2 Dry Powder Inhaler Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Pharmaceutical Industries Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Dry Powder Inhaler Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AKELA Pharma
2.6.1 Business Overview
2.6.2 Dry Powder Inhaler Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AKELA Pharma Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pharmaxis
2.7.1 Business Overview
2.7.2 Dry Powder Inhaler Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pharmaxis Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Hovione FarmaCiencia
2.8.1 Business Overview
2.8.2 Dry Powder Inhaler Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hovione FarmaCiencia Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nanotherapeutics
2.9.1 Business Overview
2.9.2 Dry Powder Inhaler Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nanotherapeutics Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 OPKO Health
2.10.1 Business Overview
2.10.2 Dry Powder Inhaler Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 OPKO Health Dry Powder Inhaler Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dry Powder Inhaler Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dry Powder Inhaler Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dry Powder Inhaler Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dry Powder Inhaler Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Dry Powder Inhaler Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dry Powder Inhaler Devices Market Analysis by Regions
4.1 Global Dry Powder Inhaler Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Dry Powder Inhaler Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dry Powder Inhaler Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
4.3 Europe Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
4.5 South America Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
5 North America Dry Powder Inhaler Devices by Countries
5.1 North America Dry Powder Inhaler Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Dry Powder Inhaler Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dry Powder Inhaler Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
5.3 Canada Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
6 Europe Dry Powder Inhaler Devices by Countries
6.1 Europe Dry Powder Inhaler Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Dry Powder Inhaler Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dry Powder Inhaler Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
6.3 UK Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
6.4 France Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
6.5 Russia Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
6.6 Italy Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dry Powder Inhaler Devices by Countries
7.1 Asia-Pacific Dry Powder Inhaler Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dry Powder Inhaler Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dry Powder Inhaler Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
7.3 Japan Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
7.4 Korea Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
7.5 India Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
8 South America Dry Powder Inhaler Devices by Countries
8.1 South America Dry Powder Inhaler Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Dry Powder Inhaler Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dry Powder Inhaler Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dry Powder Inhaler Devices by Countries
9.1 Middle East and Africa Dry Powder Inhaler Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dry Powder Inhaler Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dry Powder Inhaler Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
9.3 UAE Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Dry Powder Inhaler Devices Sales and Growth Rate (2013-2018)
10 Global Dry Powder Inhaler Devices Market Segment by Type
10.1 Global Dry Powder Inhaler Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dry Powder Inhaler Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Dry Powder Inhaler Devices Revenue and Market Share by Type (2013-2018)
10.2 Capsule Based Sales Growth and Price
10.2.1 Global Capsule Based Sales Growth (2013-2018)
10.2.2 Global Capsule Based Price (2013-2018)
10.3 Blister Based Sales Growth and Price
10.3.1 Global Blister Based Sales Growth (2013-2018)
10.3.2 Global Blister Based Price (2013-2018)
10.4 Reservoir/Cartridge Based Sales Growth and Price
10.4.1 Global Reservoir/Cartridge Based Sales Growth (2013-2018)
10.4.2 Global Reservoir/Cartridge Based Price (2013-2018)
11 Global Dry Powder Inhaler Devices Market Segment by Application
11.1 Global Dry Powder Inhaler Devices Sales Market Share by Application (2013-2018)
11.2 Hospitals and Clinics Sales Growth (2013-2018)
11.3 Others Sales Growth (2013-2018)
12 Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.1 Global Dry Powder Inhaler Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Dry Powder Inhaler Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.2.2 Europe Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.2.4 South America Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dry Powder Inhaler Devices Market Forecast (2018-2023)
12.3 Dry Powder Inhaler Devices Market Forecast by Type (2018-2023)
12.3.1 Global Dry Powder Inhaler Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Dry Powder Inhaler Devices Market Share Forecast by Type (2018-2023)
12.4 Dry Powder Inhaler Devices Market Forecast by Application (2018-2023)
12.4.1 Global Dry Powder Inhaler Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Dry Powder Inhaler Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dry Powder Inhaler Devices Picture
Table Product Specifications of Dry Powder Inhaler Devices
Figure Global Sales Market Share of Dry Powder Inhaler Devices by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
